First of all, I understand that increasing the # of outstanding shares will have an impact, but if you look at what Dr Moro has been able to do with just a a few million dollars each year it is remarkable. Look where this technology has come. We sold a radioisotope test to Abbott. Those few million dollars will finally translate into revenue. The test is ready for oncopet. IMO, that is is first goal to begin a revenue stream. I agree that Dr Moro should have a roadmap that he can justify the amount of shares necessary to accomplish this. We are about to enter new territory. The fact that he added 2 new executives with experience should restore a bit more confidence in the longterm strategy of the company. It may be hard to pin point exact figures for Dr Moro, but I agree he should acknowledge where the money is going. I am certain there is a need for cash on the balance sheet in case we ever experience another collapse in the financial markets. I hope he plans to address shareholders prior to the shareholder meeting. I would also like to hear about the reception he was given at this year's ISOBM.